Current drug therapies are aimed at increasing the FL-SMN transcripts produced from SMN2. Potential large complex rearrangements of the SMN region may play a role in the SMA disease mechanism in the black SA population and may influence diagnosis and potentially the effect of drug therapies. This evidence concerns the gene SMN1 and proximal spinal muscular atrophy.